Zika virus-reigniting the TORCH

Nature Reviews Microbiology

Volumn 14, Issue 11, 2016, Pages 707-715

  Coyne, Carolyn B ^a,b   Lazear, Helen M ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PLACENTA BARRIER; CONGENITAL DISORDER; CONGENITAL RUBELLA SYNDROME; CONGENITAL TOXOPLASMOSIS; CYTOMEGALOVIRUS; HERPES SIMPLEX VIRUS; HUMAN; MICROCEPHALY; NONHUMAN; PATHOGENESIS; PLACENTA FUNCTION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RUBELLA VIRUS; TERATOGENICITY; TOXOPLASMA GONDII; VERTICAL TRANSMISSION; VIRUS LOAD; ZIKA FEVER; ZIKA VIRUS; ANIMAL; COMPLICATION; CYTOLOGY; FEMALE; FETUS; FETUS DISEASE; PATHOGENICITY; PHYSIOLOGY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TRANSMISSION; VIROLOGY; ZIKA VIRUS INFECTION;

ANIMALS; FEMALE; FETAL DISEASES; FETUS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84984622151     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2016.125     Document Type: Review

References (105)

1. Dick, G. W., Kitchen, S. F. & Haddow, A. J. Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46, 509-520 (1952).
2. Lazear, H. M. & Diamond, M. S. Zika virus: new clinical syndromes and its emergence in the Western hemisphere. J. Virol. 90, 4864-4875 (2016).
3. Fauci, A. S. & Morens, D. M. Zika virus in the Americas - yet another arbovirus threat. N. Engl. J. Med. 374, 601-604 (2016).
4. Simpson, D. I. Zika virus infection in man. Trans. R. Soc. Trop. Med. Hyg. 58, 335-338 (1964).
5. Bearcroft, W. G. Zika virus infection experimentally induced in a human volunteer. Trans. R. Soc. Trop. Med. Hyg. 50, 442-448 (1956).
6. Zanluca, C. et al. First report of autochthonous transmission of Zika virus in Brazil. Mem. Inst. Oswaldo Cruz 110, 569-572 (2015).
7. Campos, G. S., Bandeira, A. C. & Sardi, S. I. Zika virus outbreak, Bahia, Brazil. Emerg. Infect. Dis. 21, 1885-1886 (2015).
8. Faria, N. R. et al. Zika virus in the Americas: Early epidemiological and genetic findings. Science 352, 345-349 (2016).
9. Schuler-Faccini, L. et al. Possible association between Zika virus infection and microcephaly - Brazil, 2015. MMWR. Morb. Mortal. Wkly Rep. 65, 59-62 (2016).
10. Cauchemez, S. et al. Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet 387, 2125-2132 (2016).
11. Oliveira Melo, A. S. et al. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet. Gynecol. 47, 6-7 (2016).
12. Ventura, C. V., Maia, M., Bravo-Filho, V., Gois, A. L. & Belfort, R. Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet 387, 228 (2016).
13. Rasmussen, S. A., Jamieson, D. J., Honein, M. A. & Petersen, L. R. Zika virus and birth defects - reviewing the evidence for causality. N. Engl. J. Med. 374, 1981-1987 (2016).
14. Sarno, M. et al. Zika virus infection and stillbirths: a case of hydrops fetalis, hydranencephaly and fetal demise. PLoS Negl. Trop. Dis. 10, e0004517 (2016).
15. Johansson, M. A., Mier-y-Teran-Romero, L., Reefhuis, J., Gilboa, S. M. & Hills, S. L. Zika and the risk of microcephaly. N. Engl. J. Med. 375, 1-4 (2016).
16. Franca, G. V. et al. Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation. Lancet http://dx.doi. org/10.1016/S0140-6736(16)30902-3 (2016).
17. Corona-Rivera, J. R. et al. Report and review of the fetal brain disruption sequence. Eur. J. Pediatr. 160, 664-667 (2001).
18. Petersen, E. E. et al. Update: interim guidance for health care providers caring for women of reproductive age with possible Zika virus exposure - United States, 2016. MMWR. Morb. Mortal. Wkly Rep. 65, 315-322 (2016).
19. Brasil, P. et al. Zika virus infection in pregnant women in Rio de Janeiro - preliminary report. N. Engl. J. Med. http://dx.doi.org/10.1056/NEJMoa1602412 (2016).
20. Ventura, C. V. et al. Ophthalmological findings in infants with microcephaly and presumable intra-uterus Zika virus infection. Arq. Bras. Oftalmol. 79, 1-3 (2016).
21. Chan, J. F., Choi, G. K., Yip, C. C., Cheng, V. C. & Yuen, K. Y. Zika fever and congenital Zika syndrome: An unexpected emerging arboviral disease. J. Infect. 72, 507-524 (2016).
22. Hustin, J. & Schaaps, J. P. Echographic [corrected] and anatomic studies of the maternotrophoblastic border during the first trimester of pregnancy. Am. J. Obstet. Gynecol. 157, 162-168 (1987).
23. Foidart, J. M., Hustin, J., Dubois, M. & Schaaps, J. P. The human placenta becomes haemochorial at the 13th week of pregnancy. Int. J. Dev. Biol. 36, 451-453 (1992).
24. Burton, G. J., Jauniaux, E. & Watson, A. L. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am. J. Obstet. Gynecol. 181, 718-724 (1999).
25. Nahmias, A. J. et al. Perinatal risk associated with maternal genital herpes simplex virus infection. Am. J. Obstet. Gynecol. 110, 825-837 (1971).
26. Plotkin, S. A. Rubella eradication. Vaccine 19, 3311-3319 (2001).
27. Schantz-Dunn, J. & Nour, N. M. Malaria and pregnancy: a global health perspective. Rev. Obstet. Gynecol. 2, 186-192 (2009).
28. Martines, R. B. et al. Pathology of congenital Zika syndrome in Brazil: a case series. Lancet http://dx.doi. org/10.1016/S0140-6736(16)30883-2 (2016).
29. Pacheco, O. et al. Zika virus disease in Colombia - preliminary report. N. Engl. J. Med. http://dx.doi. org/10.1056/NEJMoa1604037 (2016).
30. Ventura, C. V., Maia, M., Dias, N., Ventura, L. O. & Belfort, R. Zika: neurological and ocular findings in infant without microcephaly. Lancet 387, 2502 (2016).
31. US National Institutes of Health. NIH launches large study of pregnant women in areas affected by Zika virus. NIH https://www.nih.gov/news-events/news-releases/nih-launches-large-study-pregnant-women-areas-affected-zika-virus (2016).
32. Robbins, J. R., Skrzypczynska, K. M., Zeldovich, V. B., Kapidzic, M. & Bakardjiev, A. I. Placental syncytiotrophoblast constitutes a major barrier to vertical transmission of Listeria monocytogenes. PLoS Pathog. 6, e1000732 (2010).
33. Robbins, J. R., Zeldovich, V. B., Poukchanski, A., Boothroyd, J. C. & Bakardjiev, A. I. Tissue barriers of the human placenta to infection with Toxoplasma gondii. Infect. Immun. 80, 418-428 (2012).
34. Bayer, A. et al. Human trophoblasts confer resistance to viruses implicated in perinatal infection. Am. J. Obstet. Gynecol. 212, 71 (2015).
35. Delorme-Axford, E. et al. Human placental trophoblasts confer viral resistance to recipient cells. Proc. Natl Acad. Sci. USA 110, 12048-12053 (2013).
36. Bayer, A. et al. Type III interferons produced by human placental trophoblasts confer protection against Zika virus infection. Cell Host Microbe 19, 705-712 (2016).
37. Zeldovich, V. B. et al. Placental syncytium forms a biophysical barrier against pathogen invasion. PLoS Pathog. 9, e1003821 (2013).
38. Tabata, T. et al. Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission. Cell Host Microbe http://dx.doi. org/10.1016/j.chom.2016.07.002 (2016).
39. Driggers, R. W. et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N. Engl. J. Med. 374, 2142-2151 (2016).
40. Miner, J. J. et al. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165, 1081-1091 (2016).
41. Maltepe, E., Bakardjiev, A. I. & Fisher, S. J. The placenta: transcriptional, epigenetic, and physiological integration during development. J. Clin. Invest. 120, 1016-1025 (2010).
42. Kim, K. & Shresta, S. Neuroteratogenic viruses and lessons for Zika virus models. Trends Microbiol. 24, 622-636 (2016).
43. Quicke, K. M. et al. Zika virus infects human placental macrophages. Cell Host Microbe 20, 83-90 (2016).
44. Adams, K. M. & Nelson, J. L. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 291, 1127-1131 (2004).
45. Maidji, E., McDonagh, S., Genbacev, O., Tabata, T. & Pereira, L. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am. J. Pathol. 168, 1210-1226 (2006).
46. Guzman, M. G., Alvarez, M. & Halstead, S. B. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch. Virol. 158, 1445-1459 (2013).
47. de Alwis, R. et al. Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera. PLoS Pathog. 10, e1004386 (2014).
48. Castanha, P. M. et al. Placental transfer of dengue virus (DENV)-specific antibodies and kinetics of DENV infection-enhancing activity in Brazilian infants. J. Infect. Dis. 214, 265-272 (2016).
49. Lanciotti, R. S. et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14, 1232-1239 (2008).
50. Dejnirattisai, W. et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat. Immunol. http://dx.doi. org/10.1038/ni.3515 (2016).
51. Priyamvada, L. et al. Human antibody responses after Dengue virus infection are highly cross-reactive to Zika virus. Proc. Natl Acad. Sci. USA 113, 7852-7857 (2016).
52. Swanstrom, J. A. et al. Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus. mBio 7, e01123-16 (2016).
53. Stettler, K. et al. Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection. Science http://dx.doi.org/10.1126/science.aaf8505 (2016).
54. Dancis, J., Lind, J., Oratz, M., Smolens, J. & Vara, P. Placental transfer of proteins in human gestation. Am. J. Obstet. Gynecol. 82, 167-171 (1961).
55. Bright, N. A. & Ockleford, C. D. Cytotrophoblast cells: a barrier to maternofetal transmission of passive immunity. J. Histochem. Cytochem. 43, 933-944 (1995).
56. Gusdon, J. P. Fetal and maternal immunoglobulin levels during pregnancy. Am. J. Obstet. Gynecol. 103, 895-900 (1969).
57. Garty, B. Z., Ludomirsky, A., Danon, Y. L., Peter, J. B. & Douglas, S. D. Placental transfer of immunoglobulin G subclasses. Clin. Diagn. Lab Immunol. 1, 667-669 (1994).
58. Malek, A., Sager, R., Kuhn, P., Nicolaides, K. H. & Schneider, H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am. J. Reprod. Immunol. 36, 248-255 (1996).
59. Dudley, D. M. et al. A rhesus macaque model of Asian-lineage Zika virus infection. Nat. Commun. 7, 12204 (2016).
60. Prisant, N. et al. Zika virus in the female genital tract. Lancet Infect. Dis. http://dx.doi.org/10.1016/S1473- 3099(16)30193-1 (2016).
61. Mlakar, J. et al. Zika virus associated with microcephaly. N. Engl. J. Med. 374, 951-958 (2016).
62. Qian, X. et al. Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell 165, 1238-1254 (2016).
63. Hanners, N. W. et al. Western Zika virus in human fetal neural progenitors persists long term with partial cytopathic and limited immunogenic effects. Cell Rep. 15, 2315-2322 (2016).
64. Tang, H. et al. Zika virus infects human cortical neural progenitors and attenuates their growth. Cell Stem Cell 18, 587-590 (2016).
65. Garcez, P. P. et al. Zika virus impairs growth in human neurospheres and brain organoids. Science 352, 816-818 (2016).
66. Dang, J. et al. Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3. Cell Stem Cell http:// dx.doi.org/10.1016/j.stem.2016.04.014 (2016).
67. Cugola, F. R. et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534, 267-271 (2016).
68. Lazear, H. M. et al. A mouse model of Zika virus pathogenesis. Cell Host Microbe 19, 720-730 (2016).
69. Rossi, S. L. et al. Characterization of a novel murine model to study Zika virus. Am. J. Trop. Med. Hyg. 94, 1362-1369 (2016).
70. Aliota, M. T. et al. Characterization of lethal Zika virus infection in AG129 mice. PLoS Negl. Trop. Dis. 10, e0004682 (2016).
71. Dowall, S. D. et al. A susceptible mouse model for Zika virus infection. PLoS Negl. Trop. Dis. 10, e0004658 (2016).
72. Wu, K. Y. et al. Vertical transmission of Zika virus targeting the radial glial cells affects cortex development of offspring mice. Cell Res. 26, 645-654 (2016).
73. Schmidt, A., Morales-Prieto, D. M., Pastuschek, J., Frohlich, K. & Markert, U. R. Only humans have human placentas: molecular differences between mice and humans. J. Reprod. Immunol. 108, 65-71 (2015).
74. Wack, A., Terczynska-Dyla, E. & Hartmann, R. Guarding the frontiers: the biology of type III interferons. Nat. Immunol. 16, 802-809 (2015).
75. Li, C. et al. Zika virus disrupts neural progenitor development and leads to microcephaly in mice. Cell Stem Cell 19, 120-126 (2016).
76. Dick, G. W. Zika virus. II. Pathogenicity and physical properties. Trans. R. Soc. Trop. Med. Hyg. 46, 521-534 (1952).
77. Paixao, E. S., Teixeira, M. G., Costa, M. D. & Rodrigues, L. C. Dengue during pregnancy and adverse fetal outcomes: a systematic review and meta-analysis. Lancet Infect. Dis. 16, 857-865 (2016).
78. Shepard, D. S., Undurraga, E. A., Halasa, Y. A. & Stanaway, J. D. The global economic burden of dengue: a systematic analysis. Lancet Infect. Dis. 16, 935-941 (2016).
79. Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504-507 (2013).
80. Kinney, J. S. & Kumar, M. L. Should we expand the TORCH complex? A description of clinical and diagnostic aspects of selected old and new agents. Clin. Perinatol. 15, 727-744 (1988).
81. Musso, D. et al. Potential sexual transmission of Zika virus. Emerg. Infect. Dis. 21, 359-361 (2015).
82. Hills, S. L. et al. Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission - continental United States, 2016. MMWR. Morb. Mortal. Wkly Rep. 65, 215-216 (2016).
83. Deckard, D. T. et al. Male-to-male sexual transmission of Zika virus - Texas, January 2016. MMWR. Morb. Mortal. Wkly Rep. 65, 372-374 (2016).
84. D'Ortenzio, E. et al. Evidence of sexual transmission of Zika virus. N. Engl. J. Med. 374, 2195-2198 (2016).
85. Foy, B. D. et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg. Infect. Dis. 17, 880-882 (2011).
86. Davidson, A., Slavinski, S., Komoto, K., Rakeman, J. & Weiss, D. Suspected female-to-male sexual transmission of Zika virus - New York City, 2016. MMWR. Morb. Mortal. Wkly Rep. 65, 716-717 (2016).
87. Mansuy, J. M. et al. Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen? Lancet Infect. Dis. 16, 405 (2016).
88. Duffy, M. R. et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med. 360, 2536-2543 (2009).
89. Besnard, M. et al. Congenital cerebral malformations and dysfunction in fetuses and newborns following the 2013 to 2014 Zika virus epidemic in French Polynesia. Euro Surveill. http://dx.doi.org/10.2807/1560-7917. ES.2016.21.13.30181 (2016).
90. Liotta, G. et al. Elimination of mother-to-child transmission of HIV infection: the drug resource enhancement against AIDS and malnutrition model. Int. J. Environ. Res. Public Health 12, 13224-13239 (2015).
91. Stevens, J. & Lyall, H. Mother to child transmission of HIV: what works and how much is enough? J. Infect. 69 (Suppl. 1), S56-S62 (2014).
92. Perkins, T. A., Siraj, A. S., Ruktanonchai, C. W., Kraemer, M. U. G. & Tatem, A. J. Model-based projections of Zika virus infections in childbearing women in the Americas. Nat. Microbiol. 1, 16126 (2016).
93. Lambert, N., Strebel, P., Orenstein, W., Icenogle, J. & Poland, G. A. Rubella. Lancet 385, 2297-2307 (2015).
94. Manicklal, S., Emery, V. C., Lazzarotto, T., Boppana, S. B. & Gupta, R. K. The "silent" global burden of congenital cytomegalovirus. Clin. Microbiol. Rev. 26, 86-102 (2013).
95. Torgerson, P. R. & Mastroiacovo, P. The global burden of congenital toxoplasmosis: a systematic review. Bull. World Health Organ. 91, 501-508 (2013).
96. Rossant, J. & Cross, J. C. Placental development: lessons from mouse mutants. Nat. Rev. Genet. 2, 538-548 (2001).
97. Schleiss, M. R. Developing a vaccine against congenital cytomegalovirus (CMV) infection: what have we learned from animal models? where should we go next? Future Virol. 8, 1161-1182 (2013).
98. Carter, A. M. Animal models of human placentation - a review. Placenta 28 (Suppl. A), S41-S47 (2007).
99. World Health Organization. Zika situation report. WHO http://www,who.int/emergencies/zika-virus/ situation-report/14-july-2016/en/ (2016).
100. Perez, S. et al. Confirmed case of Zika virus congenital infection, Spain, March 2016. Euro Surveill. http://dx. doi.org/10.2807/1560-7917.ES.2016.21.24.30261 (2016).
101. Culjat, M. et al. Clinical and imaging findings in an infant with Zika embryopathy. Clin. Infect. Dis. http:// dx.doi.org/10.1093/cid/ciw324 (2016).
102. Aiken, A. R. et al. Requests for abortion in Latin America related to concern about Zika virus exposure. N. Engl. J. Med. 375, 396-398 (2016).
103. Oster, A. M. et al. Update: interim guidance for prevention of sexual transmission of Zika virus - United States, 2016. MMWR. Morb. Mortal. Wkly Rep. 65, 323-325 (2016).
104. Guttmacher Institute. Facts on abortion in Latin America and the Caribbean. Guttmacher Institute https://www.guttmacher.org/fact-sheet/facts-abortion-latin-america-and-caribbean (2015).
105. McConkey, C. A. et al. A three-dimensional culture system recapitulates placental syncytiotrophoblast development and microbial resistance. Sci. Adv. 2, e1501462 (2016).